Zicix Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ZICX | MASK | LZMH | FOXX | AVX | ZSQR | |
|---|---|---|---|---|---|---|
| Market cap | 2.98M | 2.91M | 7.85M | 15.28M | 44.34M | 213.86M |
| P/E (TTM) | — | 1.2 | — | — | 0.0 | — |
| Forward P/E | — | — | — | — | — | — |
| Price/book | -1.4 | 0.1 | 1.0 | -0.3 | 0.3 | 1.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −80.79% | −93.76% | −98.63% | −49.53% | −89.92% | −73.33% |
| Today | 0.00% | −1.71% | −1.00% | −11.75% | −7.88% | −5.72% |
The closest companies by business and industry (Software - Application). Prices may be delayed up to 15 min.
Latest news
All ZICX news ›Zicix Corp 1Q 2026: Revenue $0 Net income ($653.62K), EPS ($0.05) — 10-Q Summary
TradingView Zicix Corp 1Q 2026: Revenue $0 Net income ($653.62K), EPS ($0.05) — 10-Q Summary Zicix Corp reported first-quarter 2026 results showing no revenue for the quarter and a net loss of $653.62K, or diluted loss per share of…
Zicix Corp FY 2026: Revenue $730.56K, EPS ($0.19) — 10-K Summary
TradingView Zicix Corp FY 2026: Revenue $730.56K, EPS ($0.19) — 10-K Summary Zicix Corp reported fiscal 2026 results showing revenue rose to $730.56K from $70.07K in 2025, while the company recorded a net loss of ($1.39M) and diluted loss…
Zicix (OTCMKTS:ZICXD) Stock Jumps 290% – Time to Buy?
Posted by Tristan Rich on Oct 15th, 2026 Shares of Zicix Corp. (OTCMKTS:ZICXD – Get Free Report) shot up 290% during trading on Wednesday. The stock traded as high as $0.2344 and last traded at $0.2344. 199 shares traded hands during…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
tradingview.com2
-
themarketsdaily.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.